Optimizing Therapeutic Base Editing for Hereditary Tyrosinemia Type 1

被引:0
|
作者
Dumitru, Ana Maria [1 ]
Berkowitz, Cara [1 ]
Whittaker, Madelynn [2 ]
Wang, Xiao [3 ]
Kus, Nicole [1 ]
Luks, Valerie [1 ]
Riley, John [1 ]
Carpenter, Marco [1 ]
Archer, Nicholas F. [4 ]
Brooks, Dominique [3 ]
Johnston, William [1 ]
Alameh, Mohamad Gabriel [5 ]
Musunuru, Kiran [2 ]
Peranteau, William [1 ]
机构
[1] Childrens Hosp Philadelphia, Philadelphia, PA USA
[2] Univ Penn, Philadelphia, PA USA
[3] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA USA
[4] Drexel Univ, Coll Med, Philadelphia, PA USA
[5] Univ Penn, Engn mRNA & Targeted Nanomed Core, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
153
引用
收藏
页码:83 / 84
页数:2
相关论文
共 50 条
  • [31] Nitisinone for the treatment of hereditary tyrosinemia type I
    McKiernan, Patrick James
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (06): : 491 - 497
  • [32] Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
    Park, Hyung-Doo
    Lee, Dong Hwan
    Choi, Tae-Youn
    Lee, You Kyoung
    Kim, Jong-Won
    Ki, Chang-Seok
    Lee, Yong-Wha
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (08) : 930 - 933
  • [33] In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type 1
    Labie, D
    M S-MEDECINE SCIENCES, 2000, 16 (03): : 419 - 420
  • [34] Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1
    Maiorana, A.
    Malamisura, M.
    Emma, F.
    Boenzi, S.
    Di Ciommo, V. M.
    Dionisi-Vici, C.
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (03) : 188 - 193
  • [35] Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients
    Ayse Cigdem Aktuglu Zeybek
    Ertugrul Kiykim
    Salim Neselioglu
    Halise Zeynep Iscan
    Tanyel Zubarioglu
    Mehmet Serif Cansever
    Ozcan Erel
    Pediatric Research, 2022, 92 : 474 - 479
  • [36] Amino acid levels and nutritional outcomes in children with hereditary tyrosinemia type 1
    Brockett, J.
    Evans, M.
    Allender, B.
    Pandithan, D.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 : 12 - 13
  • [37] Waddling gait and invalidating rickets as presenting signs of hereditary tyrosinemia type 1
    Rigante, D
    Holme, E
    Segni, G
    Stabile, A
    Caradonna, P
    BONE, 2001, 28 (05) : S119 - S119
  • [38] Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways
    van Dyk, E.
    Steenkamp, A.
    Koekemoer, G.
    Pretorius, P. J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (01) : 32 - 36
  • [39] Preclinical Assessment of an In Vivo Lentiviral Vector Cure for Hereditary Tyrosinemia Type 1
    Kaiser, Robert A.
    Nicolas, Clara T.
    Allen, Kari L.
    VanLith, Caitlin J.
    Du, Zeji
    Hillin, Lori G.
    Cao, William
    Bhagwate, Aditya
    O'Brien, Daniel
    Kocher, Jean-Pierre
    Hickey, Raymond D.
    Mondal, Gourish
    Lillegard, Joseph B.
    MOLECULAR THERAPY, 2020, 28 (04) : 426 - 426
  • [40] Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients
    Zeybek, Ayse Cigdem Aktuglu
    Kiykim, Ertugrul
    Neselioglu, Salim
    Iscan, Halise Zeynep
    Zubarioglu, Tanyel
    Cansever, Mehmet Serif
    Erel, Ozcan
    PEDIATRIC RESEARCH, 2022, 92 (02) : 474 - 479